神経診断薬市場規模、シェア、成長分析：製品別、病態別、エンドユーザー別、地域別 - 産業予測 2025～2032年

神経診断薬市場規模は2023年に99億米ドルと評価され、2024年の107億9,000万米ドルから2032年には215億米ドルに成長し、予測期間（2025-2032年）のCAGRは9.0％で成長する見通しです。

神経診断市場は、神経疾患の割合の上昇、高齢化、技術の進歩によって大きな成長を遂げています。特に神経変性疾患の早期かつ正確な疾患検出における技術革新は、プロテオミクスとゲノミクスの統合を通じて診断精度を高めています。世界的に病院や診断センターの数が増加しているため、高度な診断技術へのアクセスが向上し、市場の拡大がさらに促進されています。神経学的診断における生物学的プロファイリングの需要も増加しています。しかし、厳しい規制や発展途上地域での需要の制限など、課題も残っています。とはいえ、臨床研究における神経診断薬の応用が急増していることや、新興経済圏における未開拓の可能性は、将来が有望であることを示しています。米国の神経診断薬市場は、今後数年間で大幅な成長を維持すると予測されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

神経診断薬市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 診断および画像システム
  • 脳波（EEG）システム
  • 筋電図検査（EMG）製品
  • 磁気共鳴画像（MRI）システム
  • 超音波画像診断システム
  • コンピュータ断層撮影（CT）スキャナ
  • 脳磁図（MEG）システム
  • 位置放射断層撮影（PET）システム
  • 血管造影システム
  • その他のシステム
• 臨床検査機器
  • PCR
  • 次世代シーケンシング（NGS）
  • サンガーシーケンス
  • その他の臨床診断製品
• 試薬・消耗品
  • メディアとセラ
  • 溶剤
  • 酵素タンパク質ペプチド
  • プローブ
  • バッファー
  • 抗体
  • その他の試薬

神経診断薬市場規模：病態別& CAGR（2025-2032）

• 市場概要
• 神経変性疾患
• てんかん
• 脳卒中
• 頭痛障害
• 睡眠障害
• その他の病態

神経診断薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院・手術センター
• 神経学センター
• 外来診療センター
• 診断ラボ・画像診断センター
• 調査室・学術機関

神経診断薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• GE Healthcare（US）
• Koninklijke Philips（Netherlands）
• FUJIFILM（Japan）
• Lifelines Neuro（US）
• Advanced Brain Monitoring（US）
• Nihon Kohden（Japan）
• Hoffmann-La Roche（Switzerland）
• Canon Medical Systems（Japan）
• Danaher（US）
• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• Johnson & Johnson（US）
• Medtronic（Ireland）
• Stryker（US）
• Intuitive Surgical（US）
• Zimmer Biomet（US）
• Smith & Nephew（UK）

結論と提言

Neurodiagnostics Market size was valued at USD 9.9 billion in 2023 and is poised to grow from USD 10.79 billion in 2024 to USD 21.5 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The neurodiagnostic market is witnessing significant growth driven by rising rates of neurological disorders, an aging population, and advancements in technology. Innovations in early and accurate disease detection, particularly for neurodegenerative conditions, are enhancing diagnostic precision through the integration of proteomics and genomics. The increasing number of hospitals and diagnostic centers worldwide is further promoting market expansion as access to advanced diagnostic technology improves. Demand for biological profiling in neurological diagnoses is also increasing. However, challenges remain, including stringent regulations and limited demand in developing regions. Nevertheless, the burgeoning application of neurodiagnostics in clinical studies and the untapped potential in emerging economies indicate a promising future. The US neurodiagnostics market is projected to sustain substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurodiagnostics Market Segments Analysis

Global Neurodiagnostics Market is segmented by Product, Condition, End-User and region. Based on Product, the market is segmented into Diagnostic and Imaging Systems, Clinical Testing Instruments and Reagents & Consumables. Based on Condition, the market is segmented into Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Diseases. Based on End-User, the market is segmented into Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurodiagnostics Market

The neurodiagnostics market is experiencing significant growth primarily due to the rising prevalence of neurological disorders, including epilepsy, Parkinson's disease, and Alzheimer's disease. As the number of individuals affected by these conditions continues to rise, there is an increasing demand for advanced diagnostic technologies within healthcare settings. This trend has led to a greater adoption of neurodiagnostic tools and instruments, as healthcare providers seek sophisticated solutions to accurately identify and monitor these disorders. Consequently, the market is expanding as stakeholders respond to the urgent need for effective diagnostic methodologies in the face of escalating neurological health challenges.

Restraints in the Neurodiagnostics Market

A significant obstacle in the neurodiagnostics market is the stringent regulations governing the approval and marketing of neurodiagnostic devices. These lengthy procedures and intricate guidelines can hinder innovation and postpone the launch of new technologies. Such delays adversely affect the overall expansion of the neurodiagnostics sector, especially in regions with rigorous healthcare regulations. As a result, the potential for technological advancements is stifled, making it challenging for companies to introduce innovative solutions promptly, ultimately limiting the market's growth and accessibility of neurodiagnostic services for patients who could benefit from them.

Market Trends of the Neurodiagnostics Market

The neurodiagnostics market is increasingly influenced by the advancements in genomics and personalized medicine, which are revolutionizing the approach to diagnosing and treating neurological disorders. As healthcare providers leverage genetic profiling and proteomic data, they can tailor treatments to individual patients, significantly improving therapeutic outcomes. This trend is driving demand for advanced diagnostic tools that enable precise identification of underlying genetic factors contributing to neurological conditions. Consequently, the market is witnessing a shift towards sophisticated techniques such as next-generation sequencing and high-throughput screening, enhancing the overall efficacy and personalization of patient care within the neurodiagnostic landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Neurodiagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Diagnostic and Imaging Systems
  • Electroencephalogram (EEG) Systems
  • Electromyography (EMG) Products
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Magnetoencephalogram (MEG) System
  • Position emission tomography (PET) System
  • Angiography System
  • Other Systems
• Clinical Testing Instruments
  • PCR
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Other Clinical Diagnostic Products
• Reagents & Consumables
  • Media and Serra
  • Solvents
  • Enzymes, Protein & Peptides
  • Probes
  • Buffers
  • Antibodies
  • Other Reagents

Global Neurodiagnostics Market Size by Condition & CAGR (2025-2032)

• Market Overview
• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Other Diseases

Global Neurodiagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

Global Neurodiagnostics Market Size & CAGR (2025-2032)

• North America (Product, Condition, End-User)
  • US
  • Canada
• Europe (Product, Condition, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Condition, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Condition, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Condition, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifelines Neuro (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Brain Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations